Free Communications

Friday 3 May 2024

Concert Hall

08:00 - 09:00
S3: Free Communications I.
Chair:  Klara Martinásková
08:00 - 08:07 Clinical remission and therapy-free remission in pediatric patients with moderate-to-severe atopic dermatitis treated with dupilumab: open-label extension study preliminary data
Amy Paller
08:07 - 08:14 Dupilumab in children aged 6 months–5 years with severe atopic dermatitis: 3-month results from the French early access program
Helene Aubert
08:14 - 08:21 Efficacy and safety of coacillium in children with moderate to severe alopecia areata: A randomised, double-blind, multicentre, phase 2-3 trial
Ulrike Blume - Peytavi
08:21 - 08:28 Three-year drug survival of dupilumab, cyclosporine A and methotrexate in a large multicenter cohort of pediatric atopic dermatitis patients
Lisa Van Der Rijst
08:28 - 08:35 Early dermatologic presentations of monogenic Inborn errors of immunity in children 
Janette Baloghová
08:35 - 08:42 The assessment of the plaque psoriasis treatment with etanercept among the paediatric population. Single centre study.
Aleksandra Lesiak
08:42 - 08:49 Staphylococcal Scalded Skin Syndrome (SSSS) in a tertiary pediatric hospital during a 10-year period (2009-2019)
Magdalini Louka
08:49 - 09:00 Discussion

Saturday 4 May 2024

Concert Hall

08:00 - 09:00
S7: Free Communications II.
Chair:  Carmen Salavastru
08:00 - 08:07 Diseases of the oral mucosa in childhood
Regina Fölster-Holst
08:07 - 08:14 A tale of two tuberous sclerosis complex children born to a mother with “kidney cysts”: A call for prospective diagnosis
Deyu Song
08:14 - 08:21
The new era of biological treatments on rare genodermatoses: The experience of the Padua Referral Centre (ERN-skin)
Roberto Mazzeto
08:21 - 08:28 Ichthyosis with confetti (IWC) – complicated case
Blanka Pinková
08:28 - 08:35 Effect of alpelisib therapy in a patient with superimposed mosaicism of PTEN hamartoma tumor syndrome and recurrent hypoglycemia
Lisa Weibel
08:35 - 08:42 The long-term outcomes after bleomycin sclerotherapy of lymphatic malformations in children – a single tertiary center experience
Hanna Hyvönen
08:42 - 08:49 Treating a complicated arteriovenous malformation (AVM) with trametinib in a pediatric patient who failed other treatments.
Martin Theiler
08:49 - 09:00 Discussion

ESPD OFFICE

domain

Address for official postal correspondence:

ESPD Office
c/o C-IN
5. kvetna 65, Prague Congress Centre
140 21 Prague 4
Czech Republic

Registered at:

1 Place de l'Hôpital
670 91 Strasbourg CEDEX
France

mail_outline
phone

Office phone & fax numbers

Tel: +420 296 219 620


language

Follow us

        

Copyright © 2022 European Society for Pediatric Dermatology
Powered by APPTIDE | Created by C-IN | Privacy Policy